North America leads with 49.8% market share in 2026, with US GLP-1 prescriptions reaching USD 32 billion in 2024 alone
IV Glutathione is a form of the antioxidant glutathione that is administered intravenously
,
Protocols commonly use subcutaneous injection in a loading-then-maintenance pattern over 46 week blocks, but there is no FDA-approved product or official dosing
The consultation should also cover the exact product, proposed indication, quality of evidence, FDA status, pharmacy source, dosing, possible risks, alternatives, monitoring, and the criteria used to determine whether treatment is helping
Below is a breakdown of the primary BPC-157 protocols available at our Memorial Houston location, including how each is administered and what it is best suited for